Chicago Tribune -- Recalls of heparin around the world and a tainted Chinese supply of the blood thinner’s raw ingredient are triggering a spike in prices of the blood thinner to hospitals and dialysis centers across the country amid tight supplies, a Schaumburg-based drugmaker said Thursday.
